View Older Stories View More Recent Stories

Feb 10, 2025 02:00PM ROSEN, LEADING TRIAL ATTORNEYS, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Feb 9, 2025 10:16AM ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Feb 9, 2025 08:32AM Faruqi & Faruqi Reminds Pacira Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 14, 2025 - PCRX
Feb 7, 2025 12:15PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Feb 6, 2025 06:17PM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira
Feb 5, 2025 08:01PM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Feb 4, 2025 07:56PM ROSEN, A LEADING LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Feb 3, 2025 07:51PM ROSEN, A LEADING LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Feb 2, 2025 07:48PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Feb 2, 2025 08:56AM INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira
Feb 1, 2025 04:46PM ROSEN, HIGHLY RECOGNIZED INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Jan 30, 2025 08:59PM ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Jan 30, 2025 08:01AM Pacira BioSciences (PCRX) Announces Updates to Board
Jan 30, 2025 06:03AM Truist Securities Upgrades Pacira Pharmaceuticals (PCRX) to Buy
Jan 29, 2025 08:59PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Jan 28, 2025 09:04PM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira
Jan 28, 2025 08:54PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Jan 27, 2025 08:49PM ROSEN, A LEADING LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Jan 26, 2025 08:49PM ROSEN, A TOP-RANKED LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Jan 26, 2025 08:14AM ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira
Jan 25, 2025 08:48PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Jan 24, 2025 08:48PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Jan 23, 2025 08:43PM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Jan 23, 2025 04:00PM PCRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Pacira BioSciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jan 22, 2025 08:38PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Jan 21, 2025 08:33PM ROSEN, A LEADING LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Jan 21, 2025 09:34AM Faruqi & Faruqi Reminds Pacira Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 14, 2025 - PCRX
Jan 20, 2025 08:33PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Jan 19, 2025 08:27PM ROSEN, A LEADING LAW FIRM, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Jan 19, 2025 09:34AM DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira
Jan 18, 2025 04:56PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Jan 17, 2025 04:56PM ROSEN, NATIONAL TRIAL LAWYERS, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Jan 16, 2025 05:41PM DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pacira
Jan 16, 2025 04:50PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Jan 15, 2025 04:00PM PCRX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Pacira BioSciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Jan 15, 2025 12:13PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PCRX
Jan 13, 2025 07:16AM Pacira Pharmaceuticals (PCRX) PT Raised to $30 at Needham
Jan 10, 2025 12:53PM Raymond James Reiterates Market Perform Rating on Pacira Pharmaceuticals (PCRX)
Jan 10, 2025 08:01AM Pacira BioSciences (PCRX) Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization
Jan 7, 2025 08:02AM Pacira BioSciences (PCRX) Receives FDA 510k Clearance for New iovera° SmartTip to Manage Chronic Low Back Pain via Long-lasting Medial Branch Nerve Block
Dec 19, 2024 11:16AM RBC Capital's Game Changers: 'Disruptive Forces in Biotech'
Dec 3, 2024 07:30AM Pacira BioSciences (PCRX) Awarded New U.S. Patent Covering EXPAREL Composition
Nov 14, 2024 10:06AM Pacira BioSciences (PCRX) Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee
Nov 7, 2024 07:42AM Pacira Pharmaceuticals (PCRX) PT Raised to $12 at Piper Sandler
Oct 21, 2024 08:00AM Pacira BioSciences (PCRX) Appoints Shawn Cross as Chief Financial Officer
Oct 3, 2024 08:04AM Pacira BioSciences (PCRX) Announces New Product-Specific J-Code for EXPAREL Effective January 1, 2025
Sep 26, 2024 08:03AM Pacira BioSciences (PCRX) Announces the Presentation of 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee
Sep 25, 2024 08:16AM DOMA Perpetual Sends Letter to Board of Directors of Pacira Biosciences (PCRX) to Immediately Accelerate and Increase its Share Buyback Program to Enhance Return to Shareholders
Sep 24, 2024 09:32AM Pacira Pharmaceuticals (PCRX) PT Raised to $18 at Jefferies
Aug 13, 2024 06:06AM Truist Securities Double Downgrades Pacira Pharmaceuticals (PCRX) to Sell
View More Recent Stories View Older Stories